Researcher Spotlight: Eileen Karr

Cellero’s scientists bring a wealth of immunology research expertise from diverse backgrounds. With extensive experience in a variety of biologics disciplines, our team is an ideal resource for a wide range of outsource research services. From donor collection to flow cytometric analyses, Cellero helps you reach your milestones. In this Researcher Spotlight, we introduce you…

Read more

Type 1 Diabetes PBMC and T Cells for R&D

Type 1 diabetes affects approximately 1.25 million Americans today, and that number is expected to rise dramatically to 5 million by 2050. In addition to its own health complications, diabetes can be a dangerous and deadly comorbidity for patients exposed to viruses, diseases, or other health challenges. As we have seen with the COVID-19 pandemic,…

Read more

COVID-19 Research Tools and Products

  Everything You Need to Investigate the COVID-19 Immune Response As the world continues to grapple with the coronavirus pandemic, researchers like you are working double-time to develop new COVID-19 vaccines and treatments. Our scientists have recently deployed multiple SARS-CoV-2 related products to aid in the research and development of life-saving discoveries.   Your Go-To…

Read more

Two New Types of Human Bone Marrow-Derived Stem Cells

In addition to our mobilized CD34+ stem cells collected from peripheral blood, we now offer two new types of human hematopoietic stem cells derived from their natural habitat: bone marrow! 1) Bone Marrow CD34+ Stem Cells These versatile immune cells give rise to all hematopoietic cell types — from platelets to mononuclear cells to granulocytes…

Read more

Cellero will be officially joining Charles River

We have some big news to share, and we’re glad you’re here to read about it! Today, Cellero has announced that we will officially be joining Charles River.  This exciting change will complement Charles River’s recent acquisition of HemaCare and allow our company to better serve a growing list of customers and partners across the…

Read more

Cellero Launches New Products to Support the Fight Against COVID-19

Convalescent COVID-19 T-cells, PBMC and Plasma Now Available LOWELL, MA – July 28, 2020 – Cellero, the leading provider of donor and patient collection services, GMP-grade biomaterials, characterized immune cells, and custom research services, today announced the launch of new convalescent COVID-19 blood products to support research and vaccine development. Blood products collected from convalescent…

Read more

Learn About Our Convalescent COVID-19 Plasma Donors

Plasma from convalescent COVID-19 patients has been all over the news as a proposed treatment for coronavirus, with the hope that antibodies in the plasma can neutralize the virus and prevent entry into cells. While studies into the safety and effectiveness of this treatment approach are ongoing, convalescent plasma is also needed to drive research…

Read more